IronBridge Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$13.2M Buy
165,250
+150
+0.1% +$11.9K 0.8% 46
2016
Q4
$13M Buy
165,100
+13,800
+9% +$1.07M 0.58% 56
2016
Q3
$11.8M Sell
151,300
-8,120
-5% -$589K 0.54% 56
2016
Q2
$11M Buy
159,420
+26,090
+20% +$1.8M 0.48% 65
2016
Q1
$9.51M Buy
133,330
+88,340
+196% +$5.55M 0.38% 86
2015
Q4
$2.8M Buy
44,990
+8,700
+24% +$531K 0.11% 144
2015
Q3
$2.06M Buy
+36,290
New +$1.92M 0.08% 150

Other funds holding CMD

IronBridge Capital Management's CMD Position: Q1 2017 in Review

IronBridge Capital Management increased its Cantel Medical Corporation (CMD) stake by 0.09% in Q1 2017, buying an estimated $11.9K and bringing the position to 165,250 shares worth $13.2M. The position accounts for 0.8% of the portfolio, ranked #46.

IronBridge Capital Management first reported a position in CMD in Q3 2015 and has held it in 7 quarters since. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2017.

  • IronBridge Capital Management held 165,250 shares of Cantel Medical Corporation worth $13.2M as of Q1 2017.
  • IronBridge Capital Management bought 150 Cantel Medical Corporation shares in Q1 2017, an estimated $11.9K.
  • Cantel Medical Corporation made up 0.8% of IronBridge Capital Management's portfolio in Q1 2017, its #46 holding.
  • IronBridge Capital Management first reported a position in Cantel Medical Corporation in Q3 2015 and has held it in 7 quarters since.
  • 218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.